PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity
Siyuan Zha(XinHua Hospital), Fang Liu(Shanghai Jiao Tong University)
Cited by 50
Related Papers
Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway
|Stem Cell Research & Therapy|2020|378
CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists
|Proceedings of the National Academy of Sciences|2019|26
Gut Microbial Metabolite Short-Chain Fatt Acids Partially Reverse Surgery and Anesthesia-Induced Behavior Deficits in C57BL/6J Mice
|Frontiers in Neuroscience|2021|19